3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Neoplasm Metastasis
6
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Endometrial Neoplasms
2
Advanced Breast Cancer
2
Adenocarcinoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Interventions
pembrolizumab
22
Paclitaxel
10
Carboplatin
9
Cisplatin
6
lenvatinib
4
Pemetrexed
4
Capecitabine
4
Albumin-Bound Paclitaxel
4
Oxaliplatin
3
Gemcitabine
3
Fluorouracil
3
130-nm albumin-bound paclitaxel
3
patritumab deruxtecan
2
olaparib
2
Leucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Docetaxel
2
Dexamethasone
2
Cetuximab
2
Bevacizumab
2
Axitinib
2
Acetaminophen
2
zanidatamab
1
trifluridine tipiracil drug combination
1
tislelizumab
1
regorafenib
1
pazopanib
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
trastuzumab deruxtecan
×
30 days
×
Clear all
No trials found.